Evidence map›Paper›PMID 34511649›Full record

ArticleActa histochemica et cytochemica2021

Dexmedetomidine and Phosphocreatine Post-treatment Provides Protection against Focal Cerebral Ischemia-reperfusion Injury in Rats.

Xiaofen Sun, Fang Kang, Yuxian Shen, Yujun Shen, Juan Li

RetractedOpen access · diamondAbstract readRetracted Publication
In one paragraph

Article in Acta histochemica et cytochemica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xiaofen SunDepartment of Anesthesiology, First Affiliated Hospital of the University of Science and Technology of China, No. 1 Swan Lake Road, Hefei 230036, Anhui, China.
Fang KangDepartment of Anesthesiology, First Affiliated Hospital of the University of Science and Technology of China, No. 1 Swan Lake Road, Hefei 230036, Anhui, China.
Yuxian ShenSchool of Basic Medical Sciences, Anhui Medical University, No. 81 Meishan Road, Hefei 230032, Anhui, China.
Yujun ShenSchool of Basic Medical Sciences, Anhui Medical University, No. 81 Meishan Road, Hefei 230032, Anhui, China.
Juan LiDepartment of Anesthesiology, First Affiliated Hospital of the University of Science and Technology of China, No. 1 Swan Lake Road, Hefei 230036, Anhui, China.
Anhui Medical University · CNFirst Affiliated Hospital of Henan University of Science and Technology · CNUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study we investigated the neuroprotective efficacy of dexmedetomidine (Dex) and phosphocreatine (PCr) alone or in combination in a rat model of focal cerebral ischemia-reperfusion injury (I/R). I/R was induced by intraluminal middle cerebral artery occlusion (MCAO) and reperfusion. Male Sprague-Dawley rats were randomly allocated to the Sham group and I/R group, and the I/R group was further divided into three subgroups: Dex (9 μg.kg

Indexed as

dexmedetomidineneuroprotectionphosphocreatinepost-ischemia treatmentreperfusion injury

Identifiers

PMID34511649
PMCPMC8424249
OpenAlexW3180319068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.